Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning - Concepedia

Concepedia

Publication | Closed Access

Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning

57

Citations

28

References

2018

Year

Bogdana Suchorska, Ulrich Schüller, Annamaria Biczok, Markus Lenski, Nathalie L. Albert, Armin Giese, Friedrich-Wilhelm Kreth, Birgit Ertl‐Wagner, Jörg‐Christian Tonn, Michael Ingrisch

European Journal of Cancer

Machine LearningMedicineIdh1/2 MutantPathologyCancer GenomicsHigh-grade GliomasImaging GenomicsOncologyGliomaContrast EnhancementTumor MicroenvironmentRadiology

References

	Year	Citations

Page 1

Page 1